Clinical

Dataset Information

0

SHR1701 in combination with Surufatinib as late-line treatment in advanced colorectal cancer


ABSTRACT: Interventions: dose-exploration :SHR1701 and Surufatinib;dose-expansion:SHR1701 and Surufatinib Primary outcome(s): Objective response rate Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 88738 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-06-30 | GSE269494 | GEO
| 2353932 | ecrin-mdr-crc
| 2380822 | ecrin-mdr-crc
| 2365809 | ecrin-mdr-crc
| 2359596 | ecrin-mdr-crc
| 39907 | ecrin-mdr-crc
| 2730034 | ecrin-mdr-crc
| PRJNA1122142 | ENA
2022-06-25 | GSE206741 | GEO
| 2353926 | ecrin-mdr-crc